{"id":30175,"date":"2025-06-21T13:00:06","date_gmt":"2025-06-21T13:00:06","guid":{"rendered":"https:\/\/medexperts.pro\/?p=30175"},"modified":"2025-06-21T13:26:29","modified_gmt":"2025-06-21T13:26:29","slug":"study-suggests-weight-loss-pill-is-as-effective-as-ozempic","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=30175","title":{"rendered":"Study Suggests Weight-Loss Pill is as Effective as Ozempic"},"content":{"rendered":"
<\/div>\n

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.<\/p>\n

\n
\n
\n

Doctors call the new weight-loss drugs revolutionary. Game-changing. Unprecedented.<\/p>\n

Soon, they may also call them obsolete.<\/p>\n

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful than those currently on the market.<\/p>\n

\u201cI think what we are going to see very quickly is that Wegovy has received a lot of the press attention, because it got there first,\u201d said Simon Cork, a senior lecturer at Anglia Ruskin University in England who has studied obesity. \u201cBut it will be rapidly overtaken by much more potent medications.\u201d<\/p>\n

On Saturday, researchers presented data at an annual meeting of the American Diabetes Association on perhaps the most anticipated of these medications: a daily pill. A late-stage study showed that the drug, called orforglipron, appeared to be about as effective as a weekly Ozempic injection at inducing weight loss and lowering blood sugar. It is just one of over a dozen experimental medications that researchers will share data about at the conference this weekend.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

Some of these drugs are still in early trials, but others could hit the market as soon as next year. They include medications that may lead to more weight loss than the roughly 15 to 20 percent body weight people lose on existing drugs. They may also be easier to take than weekly injections and help people shed pounds without dropping as much muscle. More competition \u2014 and, in the case of the pill, lower manufacturing costs \u2014 might also mean that, eventually, patients pay less.<\/p>\n

\u201cA lot of people are like, \u2018Oh, we have Ozempic, everything\u2019s good now,\u2019\u201d said Megan Capozzi, a research assistant professor at the University of Washington Medicine who studies treatments for diabetes and obesity. \u201cBut I think there are so many more things to improve on.\u201d<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

The drugs in development include a pill that a new trial suggests is about as effective as Ozempic.Doctors call the new weight-loss drugs revolutionary. Game-changing. Unprecedented.Soon, they may also call them obsolete.Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful than those currently on the market.\u201cI think what we are going to see very quickly is that Wegovy has received a lot of the press attention, because it got there first,\u201d said Simon Cork, a senior lecturer at Anglia Ruskin University in England who has studied obesity. \u201cBut it will be rapidly overtaken by much more potent medications.\u201dOn Saturday, researchers presented data at an annual meeting of the American Diabetes Association on perhaps the most anticipated of these medications: a daily pill. A late-stage study showed that the drug, called orforglipron, appeared to be about as effective as a weekly Ozempic injection at inducing weight loss and lowering blood sugar. It is just one of over a dozen experimental medications that researchers will share data about at the conference this weekend.Some of these drugs are still in early trials, but others could hit the market as soon as next year. They include medications that may lead to more weight loss than the roughly 15 to 20 percent body weight people lose on existing drugs. They may also be easier to take than weekly injections and help people shed pounds without dropping as much muscle. More competition \u2014 and, in the case of the pill, lower manufacturing costs \u2014 might also mean that, eventually, patients pay less.\u201cA lot of people are like, \u2018Oh, we have Ozempic, everything\u2019s good now,\u2019\u201d said Megan Capozzi, a research assistant professor at the University of Washington Medicine who studies treatments for diabetes and obesity. \u201cBut I think there are so many more things to improve on.\u201dWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":30177,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-30175","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lifestyle"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/30175","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=30175"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/30175\/revisions"}],"predecessor-version":[{"id":30178,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/30175\/revisions\/30178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/30177"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=30175"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=30175"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=30175"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}